INVO Bioscience Correlations
| INVODelisted Stock | USD 0.84 0.03 3.45% |
The current 90-days correlation between INVO Bioscience and Enveric Biosciences is -0.01 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as INVO Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if INVO Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
INVO Bioscience Correlation With Market
Very good diversification
The correlation between INVO Bioscience and DJI is -0.22 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding INVO Bioscience and DJI in the same portfolio, assuming nothing else is changed.
INVO |
Moving against INVO Stock
| 0.78 | MMM | 3M Company Fiscal Year End 28th of January 2025 | PairCorr |
| 0.53 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.45 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.38 | HYMTF | Hyundai Motor | PairCorr |
| 0.34 | TLK | Telkom Indonesia Tbk | PairCorr |
Related Correlations Analysis
| 0.21 | 0.35 | 0.52 | 0.48 | ENTX | ||
| 0.21 | 0.57 | 0.38 | -0.35 | NLSP | ||
| 0.35 | 0.57 | 0.46 | -0.15 | ENVB | ||
| 0.52 | 0.38 | 0.46 | 0.27 | LIXT | ||
| 0.48 | -0.35 | -0.15 | 0.27 | CLPS | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between INVO Stock performing well and INVO Bioscience Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze INVO Bioscience's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ENTX | 2.83 | 0.07 | (0.01) | (0.19) | 3.07 | 5.47 | 29.16 | |||
| NLSP | 4.09 | (1.15) | 0.00 | (0.94) | 0.00 | 4.71 | 33.23 | |||
| ENVB | 3.21 | (0.64) | 0.00 | (1.76) | 0.00 | 6.25 | 28.33 | |||
| LIXT | 4.49 | 0.12 | (0.01) | (0.04) | 5.73 | 7.95 | 70.38 | |||
| CLPS | 3.15 | 0.58 | 0.11 | (1.26) | 3.40 | 10.23 | 24.69 |
Delisting Warning - INVO
INVO Bioscience was delisted
| The entity INVO Bioscience with a symbol INVO was delisted from NASDAQ Exchange. Please try NAYA Biosciences, with a symbol NAYA from now on. Check all delisted instruments accross multiple markets. |
INVO Bioscience Corporate Management
| Kevin MD | Medical Director | Profile | |
| FACS FACOG | VP Integration | Profile | |
| Bojan Mitrovic | Director US | Profile | |
| Lori MarzilliKahler | VP Operations | Profile | |
| Terah Krigsvold | Controller | Profile | |
| Chris Myer | Sr Americas | Profile |
Still Interested in INVO Bioscience?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.